Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 133 Records) |
Query Trace: Lung Neoplasms and ERCC1[original query] |
---|
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2016 Aug 98 1-8. Mok Tony, Ladrera Guia, Srimuninnimit Vichien, Sriuranpong Virote, Yu Chong-Jen, Thongprasert Sumitra, Sandoval-Tan Jennifer, Lee Jin Soo, Fuerte Fatima, Shames David S, Klughammer Barbara, Truman Matt, Perez-Moreno Pablo, Wu Yi-Lo |
Fine-mapping markers of lung cancer susceptibility in a sub-region of chromosome 19q13.3 among Chinese. Oncotarget 2016 May . Yin Jiaoyang, Wang Huiwen, Vogel Ulla, Wang Chunhong, Ma Yegang, Hou Wei, Zhang Ying, Guo Li, Li Xinx |
A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis. Disease markers 2016 2016 7643981. Han Yali, Liu Jie, Sun Meili, Zhang Zongpu, Liu Chuanyong, Sun Yupi |
Effect of the ERCC1 (C118T) Polymorphism on Treatment Response in Advanced Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2016 11 17 (11): 4917-4920. Kaewbubpa Walennee, Areepium Nutthada, Sriuranpong Viro |
Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. Scientific reports 2017 Sep 7 (1): 10702. Zhang Ruoxin, Jia Ming, Xue Huijing, Xu Yuan, Wang Mengyun, Zhu Meiling, Sun Menghong, Chang Jianhua, Wei Qing |
Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis. Journal of cellular biochemistry 2017 12 118 (12): 4782-4791. Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H |
Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. Scientific reports 2017 Feb 7 42185. Pintarelli Giulia, Cotroneo Chiara Elisabetta, Noci Sara, Dugo Matteo, Galvan Antonella, Delli Carpini Simona, Citterio Lorena, Manunta Paolo, Incarbone Matteo, Tosi Davide, Santambrogio Luigi, Dragani Tommaso A, Colombo Frances |
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathology, research and practice 2017 Nov . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Calleja-Hernández Miguel Ángel, Faus-Dáder María Jo |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 90-96. Liao Wei-Yu, Ho Chao-Chi, Tsai Tzu-Hsiu, Chen Kuan-Yu, Shih Jin-Yuan, Yu Chong-J |
Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients. Oncotarget 2018 Jan 9 (1): 958-968. Du Lehui, Yu Wei, Dai Xiangkun, Zhao Nana, Huang Xiang, Tong Fang, Liu Fang, Huang Yurong, Ju Zhongjian, Yang Wei, Cong Xiaohu, Xie Chuanbin, Liu Xiaoliang, Liang Lanqing, Han Yanan, Qu Baol |
Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression. Cancer medicine 2018 Dec 7 (12): 6317-6330. Yu Tao, Xue Ping, Cui Su, Zhang Liang, Zhang Guopei, Xiao Mingyang, Zheng Xiao, Zhang Qianye, Cai Yuan, Jin Cuihong, Yang Jinghua, Wu Shengwen, Lu Xiao |
Residential radon, genetic polymorphisms in DNA damage and repair-related. Lung cancer (Amsterdam, Netherlands) 2019 Sep 135 10-15. Lorenzo-González María, Ruano-Ravina Alberto, Torres-Durán María, Kelsey Karl T, Provencio Mariano, Parente-Lamelas Isaura, Leiro-Fernández Virginia, Vidal-García Iria, Castro-Añón Olalla, Martínez Cristina, Golpe-Gómez Antonio, Torres-Español María, Abal-Arca José, Montero-Martínez Carmen, Fernández-Villar Alberto, Barros-Dios Juan |
The Relationship Between rs3212986C>A Polymorphism and Tumor Stage in Lung Cancer Patients. Cureus 2019 Apr 11 (4): e4423. Anoushirvani Ali Arash, Aghabozorgi Reza, Ahmadi Azam, Arjomandzadegan Mohammad, Khalili Sara, Sahraei Maryam, Fereydouni Taha, Khademi Zo |
ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population. Anticancer research 2019 Jun 39 (6): 3269-3272. Chaszczewska-Markowska Monika, Kosacka Monika, Chryplewicz Agnieszka, Dy?a Tomasz, Brzecka Anna, Bogunia-Kubik Katarzy |
Beyond DNA repair: the novel immunological potential of PARP inhibitors. Molecular & cellular oncology 2019 5 6 (2): 1585170. Chabanon Roman M, Soria Jean-Charles, Lord Christopher J, Postel-Vinay Soph |
Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition. Cancer science 2019 Apr . Liang Wenhua, Guo Minzhang, Pan Zhenkui, Cai Xiuyu, Li Caichen, Zhao Yi, Liang Hengrui, Yang Haiying, Wang Zhen, Chen Wenting, Xu Chuhong, Yang Xinyun, Sun Jianyu, He Ping, Gu Xia, Yin Weiqiang, He Jianxi |
Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Cancer medicine 2019 Dec . Grenda Anna, B?ach Justyna, Szczyrek Micha?, Krawczyk Pawe?, Nico? Marcin, Ku?nar Kami?ska Barbara, Jakimiec Monika, Balicka Gra?yna, Chmielewska Izabela, Batura-Gabryel Halina, Sawicki Marek, Milanowski Janu |
Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. Molecular biology reports 2020 Sep . Bushra Most Umme, Rivu Sanzana Fareen, Sifat Ali Ehsan, Nahid Noor Ahmed, Ahmed Maizbha Uddin, Al-Mamun Mir Md Abdullah, Apu Mohd Nazmul Hasan, Islam Md Siddiqul, Islam Md Reazul, Islam Mohammad Safiqul, Hasnat Ab |
The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk. Cancer genomics & proteomics 0 17 (5): 571-577. Chen Li-Hsiou, Shen Te-Chun, Li Chia-Hsiang, Chiu Kuo-Liang, Hsiau Yu-Chen, Wang Yun-Chi, Gong Chi-Li, Wang Zhi-Hong, Chang Wen-Shin, Tsai Chia-Wen, Hsia Te-Chun, Bau DA-Ti |
Polymorphisms in the BER and NER pathways and their influence on survival and toxicity in never-smokers with lung cancer. Scientific reports 2020 12 10 (1): 21147. Casal-Mouriño Ana, Ruano-Ravina Alberto, Torres-Durán María, Parente-Lamelas Isaura, Provencio-Pulla Mariano, Castro-Añón Olalla, Vidal-García Iria, Abal-Arca José, Piñeiro-Lamas María, Fernández-Villar Alberto, Valdés-Cuadrado Luis, Barros-Dios Juan Miguel, Pérez-Ríos Móni |
Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer. BMC cancer 2021 Jul 21 (1): 842. Tang Yunxiang, Zhang Ruike, Li Yinan, Xu Shuyu, Wang Hao, Xu Jingzhou, Xiao Lei, Wang Yajing, Du Jing, Huang Yujia, Su To |
The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer. Journal of thoracic disease 2021 6 13 (5): 3126-3136. Jiang Chenxue, Guo Yanling, Li Yefei, Kang Jingjing, Sun Xiaojiang, Wu Hongyu, Feng Jianguo, Xu Yapi |
Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians. Scientific reports 2021 May 11 (1): 11291. Bhat Gh Rasool, Sethi Itty, Bhat Amrita, Verma Sonali, Bakshi Divya, Sharma Bhanu, Nazir Muddasser, Dar Khursheed A, Abrol Deepak, Shah Ruchi, Kumar Rake |
Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients. Archives of medical science : AMS 2021 3 17 (2): 474-480. Nico? Marcin, Rolska-Kopi?ska Anna, Krawczyk Pawe?, Grenda Anna, Bo?yk Aleksandra, Szczyrek Micha?, Milanowski Janu |
Erratum to the association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer. Journal of thoracic disease 2022 4 14 (3): 797-798. Authors are not available |
A miR-15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum-based chemotherapy. Journal of cellular and molecular medicine 2022 10 26 (21): 5439-5451. Xue Ping, Zhang Guopei, Zhang Hongchao, Cui Su, Zhang Liang, Yu Tao, Xiao Mingyang, Li Liuli, Lu Xiao |
The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese. Journal of Cancer 2022 1 13 (2): 517-526. Lan Xueling, Li Ying, Wu Yefeng, Li Xia, Xu L |
Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy. Journal of biomolecular structure & dynamics 2023 9 1-20. Sidhartha Singh, Anu Gupta, Navneet Singh, Parth Sarthi Sengupta, Saroj Kumar Panda, Siddharth Shar |
The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer. Journal of cancer research and therapeutics 2023 10 19 (5): 1248-1254. Mustafa Karaa?aç, Ça?layan Geredeli, Mahmut Selman Y?ld?r?m, Tamer Alt?nok, ?sa Dede, Ali ?nal, Ay?e Gül Zamani, Bu?ra Kaya, Ahmet Demirkaz?k, Mehmet Art |
DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis. Clinical oncology (Royal College of Radiologists (Great Britain)) 2024 4 . W S Yiu, T S M Chu, Y Meng, F-M Spring Ko |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: